Published online Dec 14, 2014. doi: 10.3748/wjg.v20.i46.17426
Revised: April 9, 2014
Accepted: July 22, 2014
Published online: December 14, 2014
Processing time: 292 Days and 0.1 Hours
AIM: To assess the anti-cancer effect of lobaplatin on human gastric cancer cells, and to explore the underlying molecular mechanisms.
METHODS: The human gastric cancer cell lines MKN-28, AGS and MKN-45 were used. The cytotoxicity of lobaplatin was detected using an MTS cell proliferation assay. Flow cytometry was used to detect cell apoptosis using Annexin V-FITC Apoptosis Detection Kit. The expression of apoptosis-regulated genes was examined at the protein level using Western blot.
RESULTS: Lobaplatin inhibited the proliferation of human gastric cancer cells and induced apoptosis, which may be associated with the up-regulation of Bax expression, poly(ADP-ribose) polymerase (PARP) cleavage, p53 expression and the reduction of Bcl-2 expression.
CONCLUSION: The cytotoxicity of lobaplatin may be due to its ability of inducing apoptosis of gastric cancer cells, which would support the potential use of lobaplatin for the therapy of gastric cancer.
Core tip: Gastric cancer is one of the common malignancies and the main cause of death. Although cisplatin had become a primary therapeutic drug in advanced gastric cancer, drug resistance was the leading cause of treatment failure. To find an effective treatment is particularly urgent and important. Lobaplatin has been investigated in patients with advanced solid tumors, yet it has not been comprehensively studied in gastric cancer cells. In this study, we found the cytotoxicity and the apoptosis promoting effect of lobaplatin, which can provide a new basis for its clinical application in gastric cancer.